McKesson Co. (NYSE:MCK) Stock Position Raised by Capital Fund Management S.A.

Capital Fund Management S.A. lifted its stake in shares of McKesson Co. (NYSE:MCK) by 111.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 76,034 shares of the company’s stock after acquiring an additional 40,057 shares during the quarter. Capital Fund Management S.A.’s holdings in McKesson were worth $43,333,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of MCK. Brophy Wealth Management LLC acquired a new stake in shares of McKesson in the third quarter worth $219,000. Geode Capital Management LLC boosted its position in shares of McKesson by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,653,288 shares of the company’s stock worth $1,306,873,000 after buying an additional 26,299 shares during the period. Coldstream Capital Management Inc. boosted its position in shares of McKesson by 11.0% in the third quarter. Coldstream Capital Management Inc. now owns 3,292 shares of the company’s stock worth $1,664,000 after buying an additional 325 shares during the period. Toronto Dominion Bank boosted its position in shares of McKesson by 14.1% in the third quarter. Toronto Dominion Bank now owns 44,779 shares of the company’s stock worth $22,140,000 after buying an additional 5,537 shares during the period. Finally, TD Private Client Wealth LLC raised its holdings in shares of McKesson by 10.5% during the third quarter. TD Private Client Wealth LLC now owns 1,593 shares of the company’s stock worth $788,000 after acquiring an additional 151 shares in the last quarter. 85.07% of the stock is owned by institutional investors.

Insider Activity

In other news, EVP Leann B. Smith sold 188 shares of the firm’s stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total transaction of $114,602.92. Following the completion of the transaction, the executive vice president now owns 1,051 shares of the company’s stock, valued at approximately $640,679.09. This trade represents a 15.17 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Brian S. Tyler sold 8,961 shares of the firm’s stock in a transaction on Friday, February 21st. The shares were sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the transaction, the chief executive officer now directly owns 60,664 shares of the company’s stock, valued at $36,276,465.36. The trade was a 12.87 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 18,110 shares of company stock valued at $10,855,706. Insiders own 0.11% of the company’s stock.

Analyst Ratings Changes

MCK has been the subject of several recent research reports. Citigroup cut their price objective on McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Mizuho raised their target price on McKesson from $630.00 to $690.00 and gave the company a “neutral” rating in a report on Thursday, April 3rd. StockNews.com lowered McKesson from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Cfra Research lowered McKesson from a “moderate buy” rating to a “hold” rating in a report on Friday, April 4th. Finally, Evercore ISI raised their target price on McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a report on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $661.00.

McKesson Stock Up 3.0 %

Shares of NYSE:MCK opened at $672.58 on Thursday. The company’s 50 day moving average price is $639.40 and its two-hundred day moving average price is $590.22. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $728.32. The firm has a market cap of $84.29 billion, a PE ratio of 30.80, a PEG ratio of 1.29 and a beta of 0.49.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. On average, research analysts expect that McKesson Co. will post 32.77 EPS for the current year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd were given a $0.71 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a yield of 0.42%. McKesson’s dividend payout ratio is currently 13.00%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.